The TCM Treatment and Drug Development of COVID-19
In 2020, the global pandemic of COVID-19 has become the most serious public health issue of this century. Although the world has invested a lot of resources in research and development, there are no effective vaccines and therapeutic medicine so far. In traditional Chinese medicine, COVID-19 belongs to the disease “疫”, based on the traditional Chinese medicine theory and the experience of SARS treatment in 2003, the National Research Institute of Chinese Medicine (NRICM) proposed the “Guideline for the Clinical Staging and Treatment of COVID-19 in Traditional Chinese Medicine” and cooperated with four medical centers to cure 21 patients. At the same time, NRICM completed the research and development of the target formula “NRICM101”, and authorized the pharmaceutical factory to manufacture and obtain the export license. We believe “NRICM101” will provide positive assistance to the international community.